MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
11.12
-0.08
-0.67%
Opening 11:59 02/27 EST
OPEN
10.97
PREV CLOSE
11.19
HIGH
11.24
LOW
10.92
VOLUME
21.02K
TURNOVER
--
52 WEEK HIGH
17.15
52 WEEK LOW
9.80
MARKET CAP
381.85M
P/E (TTM)
-10.0316
1D
5D
1M
3M
1Y
5Y
1D
Benitec Biopharma BB-301 Phase 1b/2a Late-Breaking Abstract Accepted At 2026 Muscular Dystrophy Association Clinical And Scientific Conference
Benzinga · 4d ago
Benitec Biopharma to Present BB-301 Phase 1b/2a Interim Data at Muscular Dystrophy Association Clinical and Scientific Conference
Reuters · 4d ago
BENITEC BIOPHARMA ANNOUNCES ACCEPTANCE OF LATE- BREAKING ABSTRACT FOR THE BB-301 PHASE 1B/2A CLINICAL TREATMENT STUDY AT THE MUSCULAR DYSTROPHY ASSOCIATION CLINICAL & SCIENTIFIC CONFERENCE
Reuters · 4d ago
Weekly Report: what happened at BNTC last week (0216-0220)?
Weekly Report · 4d ago
Weekly Report: what happened at BNTC last week (0209-0213)?
Weekly Report · 02/16 10:01
Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON) and Benitec Biopharma (BNTC)
TipRanks · 02/14 01:30
Benitec Biopharma Q2 EPS $(0.26) Misses $(0.22) Estimate
Benzinga · 02/12 14:07
Benitec GAAP EPS of -$0.26 misses by $0.03
Seeking Alpha · 02/12 13:54
More
About BNTC
Benitec Biopharma Inc is a clinical-stage biotechnology company. The Company is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.

Webull offers Benitec Biopharma Inc stock information, including NASDAQ: BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.